
-
If Iran's Khamenei falls, what would replace him?
-
India's Bumrah aiming for three Tests out of five against England
-
Mutilation ban and microchips: EU lawmakers approve cat and dog welfare rules
-
Israel minister says Iran leader 'can no longer exist' after hospital hit
-
Thai PM clings on as crisis threatens to topple government
-
Govts scramble to evacuate citizens from Israel and Iran
-
Floods expected after Hurricane Erick makes landfall in western Mexico
-
Russia warns US against 'military intervention' in Iran-Israel war
-
Budapest mayor defies police ban on Pride march
-
Air India says plane 'well-maintained' before crash
-
Arctic warming spurs growth of carbon-soaking peatlands
-
Swiss central bank cuts interest rates to zero percent
-
Bordeaux-Begles 'underdogs' before Top 14 semis despite Champions Cup triumph
-
Gattuso convinced Italy can reach World Cup
-
Relieved Pakistanis recall 'horrifying nights' as Israel, Iran trade strikes
-
England v India: Three key battles
-
Stocks drop, oil gains as Mideast unrest fuels inflation fears
-
Israel's Netanyahu says Iran will 'pay heavy price' after hospital hit
-
France steps closer to defining rape as lack of consent
-
SpaceX Starship explodes during routine test
-
Belgrade show plots path out of Balkan labyrinth of pain
-
Thailand's 'Yellow Shirts' return to streets demand PM quit
-
Stocks drop after Fed comments as Mideast fears lift crude
-
Govts scramble to evacuate citizens from Israel, Iran
-
'Moving Great Wall': China unleash towering teen basketball star
-
Nippon Steel closes US Steel acquisition under strict conditions
-
Fundraising shift at NY pride as Trump scares off corporate donors
-
Kenyan LGBTQ community vogues despite threat of repressive law
-
Thai PM apologises as crisis threatens to topple government
-
Iran strikes Israel as Trump weighs US involvement
-
Shortages hit Nigeria's drive towards natural gas-fuelled cars
-
S.Africa's iconic protea flower relocates as climate warms
-
Thai PM faces growing calls to quit following Cambodia phone row
-
Mutilation ban and microchips: EU lawmakers vote on cat and dog welfare
-
Czechs sign record nuclear deal but questions remain
-
Suaalii fit to face Lions but O'Connor left out by Wallabies for Fiji Test
-
Myanmar's Aung San Suu Kyi marks 80th birthday in junta jail
-
Homeland insecurity: Expelled Afghans seek swift return to Pakistan
-
Mushroom murder suspect fell sick from same meal: defence
-
New Zealand coroner raises alarm over 'perilous' collision sport
-
Syrians watch Iran-Israel crossfire as government stays silent
-
India start new era without Kohli and Rohit against England
-
Asian stocks drop after Fed warning, oil dips with Mideast in focus
-
Juventus thump Al Ain in Club World Cup after Trump visit
-
Williams boost for Crusaders ahead of Chiefs Super Rugby showdown
-
Trump weighs involvement as Israel launches fresh strikes on Iran
-
Nippon, US Steel complete partnership deal
-
Chile ups hake catch limits for small-scale fishermen
-
Taiwan pursues homegrown Chinese spies as Beijing's influence grows
-
Myanmar's Aung San Suu Kyi marks 80th in junta jail

New US strategy to make monkeypox vaccine go further
US health authorities on Tuesday authorized a new procedure for injecting the monkeypox vaccine that should make it possible to inoculate more people with the same amount of the drug, at a time when doses are running short in the country.
The Food and Drug Administration also authorized giving the vaccine to people under the age of 18 who are considered to be at high risk of infection.
For those over 18, health workers will now be able to administer the vaccine differently, via an intradermal injection -- that is, between the upper layers of the skin -- and not with a deeper, subcutaneous injection.
The new method will "increase the total number of doses available for use by up to five-fold," the FDA said in a statement.
Two injections, four weeks apart, will still be necessary.
The FDA said it was drawing on data from a 2015 clinical trial that showed a similar immune response in people given a subcutaneous injection compared to those given a fifth of the dose via an intradermal shot.
At present, some 620,000 doses of the vaccine -- manufactured by Bavarian Nordic, and marketed under the name Jynneos in the United States -- have been distributed across the country.
Another 440,000 additional doses are still to be distributed, which could allow up to 2.2 million injections under the new strategy.
The government has also ordered an additional five million doses, which will start arriving from September and run through 2023, affording the potential to administer 25 million doses.
The decisions came after the FDA issued an emergency use authorization for the vaccine, a move that itself followed the declaration of a public health emergency last week.
For the authorization in minors, the FDA said it had reviewed safety data for the vaccine, as well as data for another vaccine given in children against smallpox.
"We feel very comfortable with the safety of the approach," said Peter Marks of the FDA at a press conference, noting a recent increase in the number of children who have potentially been exposed to infected people.
The United States has registered nearly 9,000 cases of monkeypox, a fifth of them in New York state. The vast majority of cases involve men who have had sex with men.
P.AbuBaker--SF-PST